FDA said it is temporarily halting its risk evaluation and mitigation strategy (REMS) program for clozapine, a treatment for schizophrenia.

Why should you factor location and state regulations into your career decision-making process? Two accomplished pharmacists provide answers and highlight their regions.

Every year, we make it a priority to involve as many student pharmacists as possible in the APhA–ASP policy development process.

APhA members representing 31 states, Puerto Rico, and the District of Columbia gathered last week to flex their political muscles at the organization’s first virtual congressional conference. Over the course of the 3-day conference, participants got a crash course on crucial pharmacy practice legislation, worked with colleagues on advocacy strategy, and met with Members of Congress and their staff.